|

Cardiopulmonary Bypass Induced Red Blood Cell Lysis

RECRUITINGSponsored by University of Maryland, Baltimore
Actively Recruiting
SponsorUniversity of Maryland, Baltimore
Started2022-03-22
Est. completion2027-12
Eligibility
Age18 Years – 88 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05189262

Summary

Studying the dynamics of red blood cell lysis, pfH, protective proteins and organ injury, limits will be set for safe levels of pfH following the use of CPB. These results will be compared to existing laboratory-based methods for determining red blood cell damage to predict CPB assist device safety. Further, results from the studies described in this proposal will help develop therapeutic strategies to benefit patients by early detection of pfH and clearance protein levels that occur during CPB.

Eligibility

Age: 18 Years – 88 YearsHealthy volunteers accepted
Inclusion Criteria:

* Admitted to UMMC for cardiac procedure
* Age: \>/=18 y.o TO 88 y.o.
* Undergoing CPB \>1hr for the following surgeries (a) complex cardiac surgery (b) heart valve replacement surgery OR (c) CABG surgery.

Exclusion Criteria:

* Pregnant
* Non English speaking
* Unable to consent or have Legally Authorized Representative (LAR) assent to study

Conditions4

Cardiac SurgeryCardiopulmonary BypassHeart DiseaseKidney Injury, Acute

Locations1 site

Center for Blood Oxygen Transport and Hemostasis
Baltimore, Maryland, 21201
Paul W Buehler, PhD410-706-5171pbuehler@som.umaryland.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.